1. Tyrosine kinase inhibitors modulate dendritic cell activity via confining c-Kit signaling and tryptophan metabolism
   Ching-Liang Chu et al, 2020, International Immunopharmacology CrossRef
2. KIT as a therapeutic target for non-oncological diseases
   Asuncion Martinez-Anton et al, 2019, Pharmacology & Therapeutics CrossRef
3. Activation through toll‐like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics
   Takashi Ishii et al, 2019, Clinical & Experimental Allergy CrossRef